Characteristics of out-of-hospital cardiac arrest cases with and out without sarcoidosis
| Cases with sarcoidosis (n=86) | Cases without sarcoidosis (n=35 109) | |
| Age (years), median (IQR) | 67 (58–75.8) | 72 (62–81) |
| Male sex, n (%) | 51 (59.30) | 23 468 (66.84) |
| Comorbidity, n (%) | ||
| Heart failure | 26 (30.23) | 7110 (20.25) |
| Ischaemic heart disease* | 26 (30.23) | 9290 (26.46) |
| Cerebrovascular disease | 13 (15.12) | 4897 (13.95) |
| Atrial fibrillation | 20 (23.26) | 6082 (17.32) |
| Peripheral artery disease | 12 (13.95) | 3902 (11.11) |
| Diabetes mellitus | 20 (23.26) | 5310 (15.12) |
| ICD/pacemaker/CRT | 7 (8.14) | 1158 (3.30) |
| Concomitant pharmacotherapy, n (%) | ||
| Renin–angiotensin system inhibitors | 30 (34.88) | 13 075 (37.24) |
| Beta blockers | 24 (27.91) | 8545 (24.34) |
| Diuretics | 56 (65.12) | 17 460 (49.73) |
| Calcium channel blockers | 14 (16.28) | 6964 (19.84) |
| Nitrates | 6 (6.98) | 3956 (11.27) |
| Antiarrhythmic drugs class 1 or 3 | <5 | 673 (1.92) |
| Antithrombotics | 43 (50.00) | 16 032 (45.66) |
| QT-prolonging drugs | 17 (19.77) | 5840 (16.63) |
Numbers are number (%) unless indicated otherwise.
*Including acute myocardial infarction.
CRT, cardiac resynchronisation therapy; ICD, implantable cardioverter defibrillator.